ATE346616T1 - Markierte ascorbinsäurederivate - Google Patents

Markierte ascorbinsäurederivate

Info

Publication number
ATE346616T1
ATE346616T1 AT00985662T AT00985662T ATE346616T1 AT E346616 T1 ATE346616 T1 AT E346616T1 AT 00985662 T AT00985662 T AT 00985662T AT 00985662 T AT00985662 T AT 00985662T AT E346616 T1 ATE346616 T1 AT E346616T1
Authority
AT
Austria
Prior art keywords
ascorbic acid
acid derivatives
labeled
alkyl
labeled ascorbic
Prior art date
Application number
AT00985662T
Other languages
English (en)
Inventor
Susan Champion
Pither Richard
Original Assignee
Ge Healthcare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ge Healthcare Ltd filed Critical Ge Healthcare Ltd
Application granted granted Critical
Publication of ATE346616T1 publication Critical patent/ATE346616T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/085—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier conjugated systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/041—Heterocyclic compounds
    • A61K51/0412—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K51/0427—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Optics & Photonics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Furan Compounds (AREA)
  • Heat Sensitive Colour Forming Recording (AREA)
  • Confectionery (AREA)
  • Pyrane Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT00985662T 1999-12-23 2000-12-22 Markierte ascorbinsäurederivate ATE346616T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP99310462 1999-12-23

Publications (1)

Publication Number Publication Date
ATE346616T1 true ATE346616T1 (de) 2006-12-15

Family

ID=8241834

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00985662T ATE346616T1 (de) 1999-12-23 2000-12-22 Markierte ascorbinsäurederivate

Country Status (9)

Country Link
US (1) US6749832B2 (de)
EP (1) EP1239886B1 (de)
JP (1) JP2003518512A (de)
AT (1) ATE346616T1 (de)
AU (1) AU2206401A (de)
CA (1) CA2394959A1 (de)
DE (1) DE60032175T2 (de)
ES (1) ES2277598T3 (de)
WO (1) WO2001047564A2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050119230A1 (en) * 2003-09-18 2005-06-02 Alexandra Glausch Pharmaceutical products comprising bisphosphonated
EP1527777A1 (de) * 2003-10-31 2005-05-04 MERCK PATENT GmbH Zubereitung mit antioxidanten Eigenschaften, die einen Benzoesäureester der Ascorbinsäure enthält
EP1875240A2 (de) * 2005-04-27 2008-01-09 Siemens Medical Solutions USA, Inc. Die herstellung von molekularen abbildungssonden unter verwendung von click chemie
DE102006037724A1 (de) * 2006-08-11 2008-02-14 Merck Patent Gmbh Verwendung von Ascorbinsäurederivaten zur Funktionalisierung von Matrices
US20130149250A1 (en) * 2011-06-23 2013-06-13 The Regents Of The University Of California Hyperpolarized agents for mri characterization of redox systems in vivo
US12509716B2 (en) * 2017-06-20 2025-12-30 Base Pair Biotechnologies, Inc. Functional ligands to target vitamin C

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4455291A (en) 1982-01-22 1984-06-19 New England Nuclear Corporation Accelerators for forming cationic technetium complexes useful as radiodiagnostic agents
US4707353A (en) * 1982-12-08 1987-11-17 Mallinckrodt, Inc. Radiographic imaging agents
US5202109A (en) 1988-06-10 1993-04-13 Neorx Corporation Conjugates for bone imaging and bone cancer therapy
US5032610A (en) 1988-11-21 1991-07-16 Norsk Hydro As Activity against carcinoma and method for the treatment of carcinoma
CZ39898A3 (cs) 1995-08-17 1998-07-15 Monsanto Company Biokonjugáty manganových komplexů makrocyklických ligandů obsahujících dusík účinné jako katalyzátory dismutace superoxidu

Also Published As

Publication number Publication date
US20030153736A1 (en) 2003-08-14
EP1239886A2 (de) 2002-09-18
JP2003518512A (ja) 2003-06-10
AU2206401A (en) 2001-07-09
ES2277598T3 (es) 2007-07-16
US6749832B2 (en) 2004-06-15
DE60032175T2 (de) 2007-09-27
CA2394959A1 (en) 2001-07-05
WO2001047564A2 (en) 2001-07-05
WO2001047564A3 (en) 2001-12-27
EP1239886B1 (de) 2006-11-29
DE60032175D1 (de) 2007-01-11

Similar Documents

Publication Publication Date Title
NO20006323D0 (no) Glykopeptidderivater og farmasöytiske sammensetninger som inneholder disse
TR200200579T2 (tr) Amino-tirazolpiridin türevleri.
TR200100432T2 (tr) Hepatit C inhibitörü tri-peptidler
DK1200418T3 (da) Nematodicide trifluorbutener
MY120235A (en) Aryloxyarylsulfonylamino hydroxamic acid derivatives
TR200100805T2 (tr) Tetrahidropiridoeterler
MA26812A1 (fr) Pyrimidine-2,4,6-triones inhibitrices de metalloproteinases
IT1311922B1 (it) Composti farmaceutici.
TR200002605T2 (tr) Nitrik oksit sentaz inhibitörleri olarak faydalı halojene amidino amino asit türevleri
ATE322487T1 (de) Hydroxamsäure-derivate
TR200001452T2 (tr) Bifenilamidin türevleri.
DE69823493D1 (de) Tetrahydropyridoverbindungen
BR9713207A (pt) Derivados de 3-mercaptoacetilamino-1,5-substituìdo-2-oxo-azepan uteis como inibidores de metaloproteinase de matriz
ATE346616T1 (de) Markierte ascorbinsäurederivate
BR0014990A (pt) Derivados de tetrahidrotiopirano ranftalazinona como inibidores de pde4
ATE166361T1 (de) Carboxymethylmannoglukan und derivate davon
BR9902084A (pt) Heterociclos.
TR200103151T2 (tr) Karboksipeptidaz U inhibitörü ile trombin inhibitörünü içeren farmasötik bir formülasyon.
TR200001026T2 (tr) Nötrofil elastaz inhibitörü olarak pirolopirolon türevleri.
DE50002107D1 (de) Alpha-liponsäure(-derivate)enthaltende retardform
PT1140932E (pt) Derivados de 1,8-benzonaftiridina
DK1097145T3 (da) Polyhydroxyalkylpyrazinderivater, deres fremstilling og lægemidler indeholdende disse derivater
BRPI9917841B8 (pt) compostos 3-ciano quinolina substituídos e composições compreendendo os mesmos
CY1110529T1 (el) Παρασκευη ν-υποκατεστημενων 2,7-διαλκυλο-4-υδροξυ-5-αμινο-8-αρυλοοκτανοϋλαμιδιων

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties